Back
  • Poster presentation
  • P-II-0624

ACR-2316: a potent, selective WEE1/PKMYT1 inhibitor rationally designed for superior single agent activity using Acrivon Predictive Precision Proteomics (AP3) for biological SAR

Appointment

Date:
Time:
Talk time:
Discussion time:
Location / Stream:
Clinical Proteomics

Session

Clinical Proteomics II

Topic

  • Clinical Proteomics

Authors

Caroline Wigerup (Lund / SE), Helén Nilsson (Lund / SE), Lei Shi (Watertown, MA / US), Joon Jung (Watertown, MA / US), Joelle Baddour-Sousounis (Watertown, MA / US), Ruban Cornelius (Lund / SE), Nina Lipjankic (Lund / SE), Uthira Muralitharan (Lund / SE), Valentina Siino (Lund / SE), Georgia Mitsa (Lund / SE), Ignacio Arribas Diez (Lund / SE), Zachary Best (Watertown, MA / US), Martina Pasetto (Lund / SE), William Dahlberg (Watertown, MA / US), Shahrzad Rafiei (Watertown, MA / US), Portia Lombardo (Watertown, MA / US), Magnus E. Jakobsson (Lund / SE), Reina Improgo (Watertown, MA / US), Christina Scherer (Watertown, MA / US), John van Duzer (Watertown, MA / US), David A. Proia (Watertown, MA / US), Kristina Masson (Lund / SE), Peter Blume-Jensen (Watertown, MA / US)

    • v1.19.0
    • © Conventus Congressmanagement & Marketing GmbH
    • Imprint
    • Privacy